Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

HER2 positive gastric cancer

Recruiting

Registered drugNo placebo

Study Comparing Rilvegostomig with Fluoropyrimidine and Trastuzumab Deruxtecan to Standard Treatment for Patients with HER2-positive Gastric Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Cardiac failure+1

Recruiting

Investigational

Study on CDR132L for Heart Failure with Reduced Ejection Fraction and Left Ventricular Hypertrophy in Adults

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Squamous cell carcinoma of lung

Recruiting

Registered drugNo placebo

Study of Pembrolizumab and MK-2870 for Patients with Metastatic Squamous Non-small Cell Lung Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drug

Study of Pembrolizumab and V940 for Treating Non-Small Cell Lung Cancer in Patients with Resectable Stage II to IIIB (N2) Not Achieving Complete Response

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Infliximab

Contact Research Centre

Atrial fibrillation

Not yet recruiting

Registered drug

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Apixaban

Contact Research Centre

Breast cancer

Not yet recruiting

Registered drugNo placebo

Study of Camizestrant plus Ribociclib as First‑Line Treatment for Patients with ER‑Positive, HER2‑Negative Advanced Breast Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Camizestrant

Contact Research Centre

Adenocarcinoma gastric+3

Not recruiting

Registered drug

Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Hypertension

Not recruiting

Investigational

Study of orforglipron in people with high blood pressure who are overweight or have obesity

Investigational

Poland

Participants:18–64 years

Contact Research Centre

Pancreatic failure

Not recruiting

Registered drugNo placebo

Study on the Effect of Pancreatic Enzyme Replacement Therapy with Pancreas Powder in Patients with Pancreatic Exocrine Insufficiency After Total Gastrectomy

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Pancreas Powder

Contact Research Centre

Breast cancer+1

Not recruiting

Registered drugNo placebo

Study of PF-07220060 and Letrozole for Postmenopausal Women with HR-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Letrozole

Contact Research Centre

Cardiac failure+4

Not recruiting

Registered drug

Study on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Cdr132L

Contact Research Centre

Find therapies in clinical trials near you – page 3

36 trials match your criteria

HER2 positive gastric cancer

Study Comparing Rilvegostomig with Fluoropyrimidine and Trastuzumab Deruxtecan to Standard Treatment for Patients with HER2-positive Gastric Cancer

Cardiac failure+1

Study on CDR132L for Heart Failure with Reduced Ejection Fraction and Left Ventricular Hypertrophy in Adults

Squamous cell carcinoma of lung

Study of Pembrolizumab and MK-2870 for Patients with Metastatic Squamous Non-small Cell Lung Cancer

Non-small cell lung cancer

Study of Pembrolizumab and V940 for Treating Non-Small Cell Lung Cancer in Patients with Resectable Stage II to IIIB (N2) Not Achieving Complete Response

Non-small cell lung cancer

Study to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

Atrial fibrillation

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Breast cancer

Study of Camizestrant plus Ribociclib as First‑Line Treatment for Patients with ER‑Positive, HER2‑Negative Advanced Breast Cancer

Adenocarcinoma gastric+3

Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

Hypertension

Study of orforglipron in people with high blood pressure who are overweight or have obesity

Pancreatic failure

Study on the Effect of Pancreatic Enzyme Replacement Therapy with Pancreas Powder in Patients with Pancreatic Exocrine Insufficiency After Total Gastrectomy

Breast cancer+1

Study of PF-07220060 and Letrozole for Postmenopausal Women with HR-Positive, HER2-Negative Breast Cancer

Cardiac failure+4

Study on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.